PCAS

Net Sales as of September 30, 2023

Ecully, October 24, 2023

NET SALES AS OF SEPTEMBER 30, 2023

PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2023.

The PCAS Group has generated consolidated net sales of €151.9 million as of September 30, 2023, a 2,7% decrease compared to the same period during the previous financial year (-2.8% at constant exchange rates).

In millions of euros		2023 9 months		2022 9 months		% change		2023 9 months at a constant exchange rate		% change
Net sales as of 30 September		151.9		156.1		-2.7%		151.7		-2.8%
Pharmaceutical Synthesis		94.6		94.3		0.3%		94.7		0.3%
Fine Specialty Chemicals (*)		57.3		61.8		-7.2%		57.1		-7.7%

(*) of which PCAS Canada sold on June 1, 2023: €13.2 million in 2023 and €16.7 million in 2022

in millions of euros	France	Other areas	Total
Net Sales by origin
September 30, 2023	108.5	43.4	151.9
September 30, 2022	118.1	38.0	156.1

Pharmaceutical Synthesis